Method of reducing chemotherapy toxicity using (methylaminopropylamino)propyl dihydrogen phosphorothioate
AssigneeU.S. Bioscience, Inc.
InventorsPhilip S. Schein, James R. Piper
Life of this patent
Estimating the term…
Abstract
A method of decreasing the toxicity of chemical therapeutic agents administered in cancer chemotherapy including adminstration to a patient undergoing chemotherapy. This reduction in toxicity can be accomplished by administering an effective amount of S-3-(3-methylaminopropylamino)propyl dihydrogen phosphorothioate. Methods of inducing mucolytic activity and reducing toxicity of acetominophen overdose are also discussed. Such activities are induced through the administration of S-3-(3-methylaminopropylamino)propyl dihydrogen phosphorothioate.
Claims4
A method of decreasing the toxicity of alkylating agents and/or platinum anti-cancer agents administered in cancer chemotherapy comprising orally administering to a patient undergoing said chemotherapy an effective amount of S-3-(3-methylaminopropylamino)propyl dihydrogen phosphorothioate.
Dependencies are inferred from the claim text.